Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

Bristol Myers Squibb (BMS) has secured another win for Opdivo (nivolumab), becoming the only FDA-approved PD-1 inhibitor for resectable non-small cell lung cancer NSCLC in both a neoadjuvant-only ...

Have a major deliverable coming up that involves lots of people and tasks? The top project management apps we've tested can help you keep your team on track. I'm an expert in software and work-related ...

Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use of nanoscale materials, such as ...

Nanocomposites are solid materials that have multiple phase domains and at least one of these domains has a nanoscale structure. The materials can have novel chemical and physical properties that ...